Sign in or create an account to add this stock to your watchlist.
About Diurnal Group (LON:DNL)
Diurnal Group plc operates as a specialty pharmaceutical company. The company develops hormone therapeutics for the treatment of rare and chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort that is in Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; Rheumacor for the treatment of inflammatory diseases; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism; and siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent cushing's syndrome. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolLON:DNL
CUSIPN/A
Phone+44-29-20682069
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-39.52%
Return on Assets-29.56%
Miscellaneous
EmployeesN/A
Outstanding Shares52,320,000
Diurnal Group (LON:DNL) Frequently Asked Questions
What is Diurnal Group's stock symbol?
Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."
How were Diurnal Group's earnings last quarter?
What price target have analysts set for DNL?
2 Wall Street analysts have issued 12-month price objectives for Diurnal Group's stock. Their forecasts range from GBX 178 to GBX 185. On average, they expect Diurnal Group's stock price to reach GBX 181.50 in the next year. View Analyst Ratings for Diurnal Group.
Who are some of Diurnal Group's key competitors?
Some companies that are related to Diurnal Group include OrganiGram (OGI), Supreme Cannabis (FIRE), OrganiGram (OGRMF), Medical Marijuana (MJNA), Benchmark (BMK), MPX Bioceutical (MPX), ICC Labs (ICC), WeedMD (WMD), Cannabis Science (CBIS), BioSyent (RX), Cipher Pharmaceuticals (CPHRF), Marijuana Company Of America (MCOA), Amryt Pharma (AMYT), Acerus Pharmaceuticals (ASP) and Indiva (NDVA).
Who are Diurnal Group's key executives?
Diurnal Group's management team includes the folowing people:
- Dr. Martin Whitaker BSc, Ph.D., Chief Exec. Officer and Exec. Director
- Prof. Richard Ross MBBS, M.D., FRCP, Chief Scientific Officer and Exec. Director
- Mr. Richard Edward Bungay BSc, ACA, Chief Financial Officer and Director (Age 49)
- Mr. Michael Withe, Commercial Director
- Mr. John Porter MBBS, Ph.D., Medical Affairs Director
Has Diurnal Group been receiving favorable news coverage?
Media stories about DNL stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Diurnal Group earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the company an impact score of 44.78 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Diurnal Group?
Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Diurnal Group's stock price today?
One share of DNL stock can currently be purchased for approximately GBX 195.
How big of a company is Diurnal Group?
Diurnal Group has a market capitalization of £160.17 million.
How can I contact Diurnal Group?
Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.
MarketBeat Community Rating for Diurnal Group (DNL)
MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote "Outperform" if you believe DNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days.
Diurnal Group (LON:DNL) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Diurnal Group in the last 12 months. Their average twelve-month price target is GBX 181.50The high price target for DNL is GBX 185 and the low price target for DNL is GBX 178. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 181.50 | GBX 181.50 | GBX 181.50 | GBX 173.50 |
Diurnal Group (LON:DNL) Consensus Price Target History
Diurnal Group (LON:DNL) Analyst Ratings History
Show:
(Data available from 5/25/2016 forward)
Diurnal Group (LON:DNL) Earnings History and Estimates Chart
Diurnal Group (LON DNL) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/12/2018 | S1 2018 | | GBX (12.70) | | | View | N/A |  |
(Earnings results data provided by Zacks Investment Research)
Diurnal Group (LON:DNL) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Diurnal Group (LON DNL) Insider Trading and Institutional Ownership History
Diurnal Group (LON DNL) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/5/2018 | John Goddard | Insider | Buy | 10,791 | GBX 540 | £58,271.40 | | |
| 11/27/2017 | Martin Whitaker | Insider | Buy | 3,703 | GBX 135 | £4,999.05 | | |
| 11/8/2017 | Martin Whitaker | Insider | Sell | 33,650 | GBX 135 | £45,427.50 | | |
| 9/7/2017 | John Goddard | Insider | Buy | 10,791 | GBX 5 | £539.55 | | |
| 1/16/2017 | Alan Raymond | Insider | Buy | 9,000 | GBX 110 | £9,900 | | |
| 1/13/2017 | Sam Williams | Insider | Buy | 9,248 | GBX 108 | £9,987.84 | | |
(Data available from 1/1/2013 forward)
Diurnal Group (LON DNL) News Headlines
| Source: |
|
Diurnal Group (LON:DNL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Diurnal Group (LON DNL) Stock Chart for Friday, May, 25, 2018
Loading chart…
